Navigation Links
IRIDEX Reports 2012 Second Quarter Results
Date:8/2/2012

MOUNTAIN VIEW, Calif., Aug. 2, 2012 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 30, 2012. Due to the sale of the Company's aesthetics laser business in February 2012, the Company's financial statements reflect the results of its aesthetics laser business as discontinued operations and the following commentary relates to the results of its continuing ophthalmology business. 

  • Revenues from ophthalmology were $8.4 million in the second quarter of 2012, up from $8.1 million in the prior year comparable period and up sequentially from $8.3 million in the first quarter of 2012.
  •  For the second quarter of 2012, net income from continuing operations was $0.4 million or $0.04 per diluted share, compared with net income from continuing operations of $0.9 million or $0.09 per diluted share reported in the second quarter of 2011.  Net income for both periods includes other income of approximately $0.8 million associated with the settlement payment from a 2007 patent lawsuit.
  • Gross margin for the second quarter of 2012 was 48.7%, comparable to 48.7% in the prior year period.  While the gross margins were just below our guided range, several non-recurring adjustments impacted cost of revenues in the period and indicate the Company's ability to drive gross margins to its target of 50% in the coming periods.
  • As anticipated, operating expenses edged up in the second quarter of 2012 to $4.5 million compared to $3.7 million in the prior year period. Costs in the second quarter of 2012 included major trade shows as well as increased spending on new marketing and product development initiatives.
  • Guidance for third quarter: The Company expects to achieve revenue between $8.4 million and $8.8 million, gross margins between 49% and 51% and operating expenses between
    '/>"/>

  • SOURCE IRIDEX Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
    2. IRIDEX Reports 2012 First Quarter Results
    3. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
    4. New Medical Device Market Research Reports Tracking over $9.5 Billion of Annual Sales Volume Now Available from GII
    5. GP Strategies Reports Record Revenue of $102 Million for Second Quarter of 2012
    6. Par Pharmaceutical Companies Reports Second Quarter 2012 Results
    7. Henry Schein Reports Record Second Quarter Results
    8. Consumer Reports Investigates Vitamins And Supplements: Ten Dangers That May Surprise You
    9. STAAR Surgical Reports Second Quarter 2012 Financial Results
    10. Thoratec Reports Second Quarter Results
    11. Masimo Reports Second Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... , Aug. 20, 2014  Decision ... (EP) mapping and ablation device market will ... ablation to treat atrial fibrillation (AF). The ... treatment option for AF will spur adoption ... application, such as advanced loop diagnostic catheters, ...
    (Date:8/20/2014)...  Amerigen Pharmaceuticals Ltd. announces that its Chinese ... Chinese FDA (CFDA) approval and has subsequently launched ... China domestic market.  Under ... with Sinochem Jiangsu Pharmaceutical Co., Ltd., Amerigen is ... and China CFDA certified oral solid dose facility ...
    (Date:8/20/2014)... NEW YORK , Aug. 20, 2014 ... available in its catalogue: Global Feminine Hygiene ... This report analyzes the worldwide markets for Feminine ... Segments: Sanitary Pads/Towels, Tampons, Panty liners, and Others. The ... Canada , Japan , ...
    Breaking Medicine Technology:Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Global Feminine Hygiene Products Industry 2Global Feminine Hygiene Products Industry 3Global Feminine Hygiene Products Industry 4Global Feminine Hygiene Products Industry 5Global Feminine Hygiene Products Industry 6Global Feminine Hygiene Products Industry 7Global Feminine Hygiene Products Industry 8Global Feminine Hygiene Products Industry 9Global Feminine Hygiene Products Industry 10Global Feminine Hygiene Products Industry 11Global Feminine Hygiene Products Industry 12Global Feminine Hygiene Products Industry 13Global Feminine Hygiene Products Industry 14Global Feminine Hygiene Products Industry 15Global Feminine Hygiene Products Industry 16Global Feminine Hygiene Products Industry 17Global Feminine Hygiene Products Industry 18Global Feminine Hygiene Products Industry 19Global Feminine Hygiene Products Industry 20Global Feminine Hygiene Products Industry 21Global Feminine Hygiene Products Industry 22Global Feminine Hygiene Products Industry 23Global Feminine Hygiene Products Industry 24Global Feminine Hygiene Products Industry 25Global Feminine Hygiene Products Industry 26
    (Date:8/21/2014)... 2014 Sometimes you have to lose the life ... book “From Zero to a Hundred: Finding My Purpose through My ... of surviving a broken family, a childhood of gang violence and ... you were created to be,” Roy said. “I didn’t give up ... know my purpose today of helping others overcome their trials.” , ...
    (Date:8/21/2014)... Michael E. Steuer , local doctor in Memphis, TN, ... City with recent philanthropy at local synagogue. “The state of ... says friend and Rabbi David Julian of Or Chadash in ... in-house for the needy and teaching Hebrew to students, Steuer ... synagogue. And to remain close with the development of Israel, ...
    (Date:8/21/2014)... Phoenix, AZ (PRWEB) August 21, 2014 ... Foundation have donated $10,000 to support ovarian cancer research, ... , Cundiff, who is also the kicker for the ... Kicking Cancer Event was matched by Colleen’s Dream Foundation ... Goodheart, MD, an Assistant Professor in the Division of ...
    (Date:8/21/2014)... 2014 Recently, BambooIndustry.com, one of the ... added a new range of hand scraped bamboo ... has launched an Autumn special offer for these elegant ... can get a discounted price, up to 25% off; ... 05. , Providing natural looks and available in ...
    (Date:8/20/2014)... 2014 Most people think of donating ... often get overlooked for a variety of reasons—thus making ... pantries. Understanding this need, Dr. Bryne Willey of ... health care center, wanted to heighten awareness of the ... first annual Thanksgiving in July food drive to collect ...
    Breaking Medicine News(10 mins):Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2Health News:AlignLife Springfield Office Donates 565 Canned Goods to Springfield Food Pantry 2
    ... VIRGINIA BEACH, Va., June 10 AMERIGROUP,Corporation (NYSE: ... full-year,2008 guidance of $2.35 to $2.45 per diluted share ... of Tennessee. As previously,announced, the Company will present at ... In the first quarter of 2008, AMERIGROUP disclosed higher ...
    ... of Christopher,Grell have filed a lawsuit against Herbalife Ltd. ... State of California (case BC392373, dept. 48) today,on behalf ... after,taking Herbalife products., The lawsuit, which also names ... Phillis Chen, a resident,of the State of California, suffered ...
    ... June 10 Mylan Inc. (NYSE: MYL ),announced ... Federal Circuit has,affirmed a May 2007 District Court ruling ... capsules do not infringe patents asserted,against Mylan by AstraZeneca. ... Mylan launched its Omeprazole products on August 4, 2003, ...
    ... June 10 More and more people today ... difficult to get and,stay healthy. This National Men,s ... that are helping people who are uninsured but,need ... this report from Pfizer (NYSE: PFE ) ...
    ... items keep addiction affordable, study says , , ... the United States have declined in recent years, but ... the decline in cigarette sales by 30 percent, a ... analyzed federal government data and found that between 2000 ...
    ... helped with depression, agitation in elderly , , TUESDAY, June ... may ease some of the behavioral problems associated with ... a hormone which seems to play a role in ... night. , Both strategies could greatly improve quality of ...
    Cached Medicine News:Health News:AMERIGROUP Provides Status on Tennessee Rate Increase and Effect on 2008 Guidance 2Health News:AMERIGROUP Provides Status on Tennessee Rate Increase and Effect on 2008 Guidance 3Health News:AMERIGROUP Provides Status on Tennessee Rate Increase and Effect on 2008 Guidance 4Health News:AMERIGROUP Provides Status on Tennessee Rate Increase and Effect on 2008 Guidance 5Health News:Herbalife Sued for Negligence and Fraud by Victim 2Health News:Decline in Cigarette Sales Offset by Use of Alternative Products 2Health News:Adding Light Eases Behavioral Problems of Dementia 2Health News:Adding Light Eases Behavioral Problems of Dementia 3
    ... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
    ... drugs of abuse tests are highly accurate in ... recommended cut-off as confirmed by GC/MS testing. The ... specific alternative method (such as GC/MS) must be ... Professional judgment should be applied to any drug ...
    ... InstaCheck® multi-drug test device provides ... easily. Negative results can be ... 3 minutes; positive results require ... one-time urine sample application will ...
    ... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
    Medicine Products: